Replies to post #185353 on Biotech Values

[DewDiligence]

TLOG +14% on clinical collaboration with MRK’s Keytruda:

http://finance.yahoo.com/news/tetralogic-merck-collaborate-evaluation-birinapant-120000330.html

TetraLogic Pharmaceuticals Corporation…and Merck…announced today they have entered into an oncology clinical study collaboration. The companies will collaborate on a Phase 1 study to evaluate the safety and efficacy of birinapant, TetraLogic’s SMAC-mimetic, in combination with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with relapsed or refractory solid tumors. The study is expected to begin in late 2015.

This is yet another I-O clinical collaboration in which no cash is changing hands.